4//SEC Filing
Cavanagh Bethany J 4
Accession 0001193125-25-230195
CIK 0001745999other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 4:15 PM ET
Size
5.0 KB
Accession
0001193125-25-230195
Insider Transaction Report
Form 4
Cavanagh Bethany J
SVP, Finance and Treasurer
Transactions
- Sale
Common Stock
2025-10-01$24.53/sh−467$11,456→ 44,045 total
Footnotes (1)
- [F1]These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. 2019 Equity Incentive Plan on September 30, 2021 and September 30, 2024. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 9, 2024.
Documents
Issuer
Beam Therapeutics Inc.
CIK 0001745999
Entity typeother
Related Parties
1- filerCIK 0002033155
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 4:15 PM ET
- Size
- 5.0 KB